Avelumab

Red

Brand Name(s):Bavencio

Indication:Merkel cell carcinoma (metastatic)

Rationale:1,2,3

Considered:Oct-17

Review Date:May-26

Comments:
NICE TA691
Avelumab is recommended as an option for treating metastatic Merkel cell carcinoma in adults who have not had chemotherapy for metastatic disease. It is recommended only if the company provides avelumab according to the commercial arrangement.

SPC has been updated with additional information regarding the new licensed indication – in combination with axitinib, avelumab is licensed for the first-line treatment of adult patients with advanced renal cell carcinoma